Important notice:Lime Trading (CY) Ltd has ceased providing its services to the UK market and UK resident investors and as a result shall exit the UK Temporary Permissions Regime (TPR) by year-end 2023, and any related UK consumer protections shall not apply from that point onwards. The Company shall remain licensed and regulated by the Cyprus Securities and Exchange Commission (CySEC).
х
Risk warning:
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers
Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7 million.
Dare Bioscience (NASDAQ:DARE) shares increased by 21.58% to $2.58. The company's market cap stands at $197.6 million.
Valneva (NASDAQ:VALN) shares increased by 9.85% to $52.73. The company's market cap stands at $2.7 billion.
Bio-Path Holdings (NASDAQ:BPTH) shares rose 8.55% to $4.82. The company's market cap stands at $34.5 million.
Nanobiotix (NASDAQ:NBTX) shares moved upwards by 8.41% to $7.73. The market value of their outstanding shares is at $269.0 million.
Scopus BioPharma (NASDAQ:SCPS) shares moved upwards by 7.87% to $2.33. The company's market cap stands at $49.1 million.
Losers
Ensysce Biosciences (NASDAQ:ENSC) shares decreased by 27.28% to $2.32 during Wednesday's pre-market session. The company's market cap stands at $56.2 million.
Unity Biotechnology (NASDAQ:UBX) stock fell 15.96% to $1.58. The company's market cap stands at $91.2 million.
VYNE Therapeutics (NASDAQ:VYNE) stock fell 6.15% to $1.07. The company's market cap stands at $57.2 million.
Calyxt (NASDAQ:CLXT) shares decreased by 5.63% to $2.35. The company's market cap stands at $90.4 million.
Novavax (NASDAQ:NVAX) stock fell 4.78% to $174.11. The market value of their outstanding shares is at $13.1 billion.
Vir Biotechnology (NASDAQ:VIR) shares declined by 4.61% to $41.0. The market value of their outstanding shares is at $5.3 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.